Item 5.07 Submission of Matters to a Vote of Security Holders. On May 21, 2026, DuPont de Nemours, Inc. (the “Company”) held its Annual Meeting of Stockholders. As of the close of business on March 30, 2026, the record date for the Annual Meeting, (the "Record Date"), 409,867,418 shares of the Company’s common stock, par value $0.01 per share, were outstanding and entitled to vote. A total of 341,319,707 shares of common stock were voted in person or by proxy, representing 83.27 percent of the shares entitled to be voted. The following are the final voting results on the matters considered and voted upon at the Annual Meeting, all of which are described in the Company’s 2026 Proxy Statement. Agenda Item 1-Election of Directors. The Company’s stockholders elected the following 10 nominees to serve on the Board of Directors of the Company until the next annual meeting of stockholders or until their successors have been duly elected and qualified. Director For Against Abstain Broker Non-Votes Amy G. Brady 285,052,183 3,175,609 497,739 52,594,176 Edward D. Breen 277,484,273 10,738,629 502,629 52,594,176 Ruby R. Chandy 285,967,600 2,066,858 691,073 52,594,176 Alexander M. Cutler 274,539,466 13,320,002 866,063 52,594,176 Eleuthère I. du Pont 283,578,696 4,649,627 497,208 52,594,176 Lori D. Koch 287,059,088 1,157,616 508,827 52,594,176 James A. Lico 286,791,310 1,391,019 543,202 52,594,176 Frederick M. Lowery 278,519,395 9,665,645 540,491 52,594,176 D.G. Macpherson 285,350,824 2,821,535 553,172 52,594,176 Kurt B. McMaken 284,975,799 3,200,207 549,525 52,594,176 Agenda Item 2-Advisory Resolution to Approve Executive Compensation. The Company’s stockholders approved, by advisory vote, the compensation of its named executive officers. For Against Abstain Broker Non-Votes 266,312,481 21,105,382 1,307,668 52,594,176 Agenda Item 3-Ratification of the Appointment of the Independent Registered Public Accounting Firm. The Company’s stockholders ratified the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for 2026. For Against Abstain Broker Non-Votes 338,791,200 1,984,333 544,174 — Agenda Item 4-Adoption and Approval of an Amendment to the Company's Certificate of Incorporation to Effect a Reverse Stock Split. The Company’s stockholders adopted and approved a proposed amendment to the Company's Certificate of Incorporation to effect a reverse stock split of the outstanding shares of the Company’s common stock at a ratio of not less than 1-for-2 or more than 1-for-4 and a reduction in the number of authorized shares of the Company's common stock by a corresponding ratio. For Against Abstain Broker Non-Votes 335,519,752 4,389,749 1,410,206 — Section 7 - Regulation FD
DD Dupont De Nemours, Inc. - 8-K
Accession
0001666700-26-0000345.077.019.01
Item 5.07 - Submission of Matters to a Vote of Security Holders
401 words
Item 7.01 - Regulation FD Disclosure
445 words
Item 7.01 Regulation FD Disclosure On May 26, 2026, the Company issued a press release announcing, among other things, that the Board of Directors of the Company approved a ratio of 1-for-3 with respect to the previously announced reverse stock split (the “Reverse Stock Split”). The Company expects that the Reverse Stock Split will become effective on June 24, 2026, however the Board of Directors of the Company retains discretion to delay or abandon the Reverse Stock Split. The press release is attached as Exhibit 99.1 and is incorporated herein by reference. The information contained in this Item 7.01, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of Section 18. Furthermore, the information contained in this report shall not be deemed to be incorporated by reference into any registration statement or other document filed pursuant to the Securities Act of 1933, as amended. Cautionary Statement Regarding Forward-Looking Statements This Current Report on Form 8-K contains “forward-looking statements” within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In this context, forward-looking statements often address expected future business and financial performance and financial condition, and often contain words such as “expect”, “anticipate”, “intend”, “plan”, “believe”, “seek”, “see”, “will”, “would”, “target”, “outlook”, “stabilization”, “confident”, “preliminary”, “initial” and similar expressions and variations or negatives of these words. All statements, other than statements of historical fact, are forward-looking statements, including statements regarding outlook, expectations and guidance, including with respect to the timing, completion, and benefits of the Reverse Stock Split. Forward-looking statements address matters that are, to varying degrees, uncertain and subject to risks, uncertainties, and assumptions, many of which that are beyond DuPont’s control, that could cause actual results to differ materially from those expressed in any forward-looking statements. Additional information concerning the risks, uncertainties and assumptions can be found in DuPont’s filings with the SEC, including its Annual Report on Form 10-K for the year ended December 31, 2025, subsequent quarterly reports on Form 10-Q and other filings. Forward-looking statements are not guarantees of future results. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. DuPont assumes no obligation to publicly provide revisions or updates to any forward-looking statements whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws. Section 9 - Financial Statements and Exhibits
Item 9.01 - Financial Statements and Exhibits
47 words
Item 9.01 Financial Statements and Exhibits. (d) Exhibits. 99.1 Press release issued by DuPont de Nemours, Inc. on May 26, 2026, announcing the Board of Directors approval of the Reverse Stock Split. 104 The cover page from this Current Report on Form 8-K, formatted in Inline XBRL.